Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation

被引:0
|
作者
Christopher S Garris
Linfeng Wu
Swati Acharya
Ahmet Arac
Victoria A Blaho
Yingxiang Huang
Byoung San Moon
Robert C Axtell
Peggy P Ho
Gary K Steinberg
David B Lewis
Raymond A Sobel
David K Han
Lawrence Steinman
Michael P Snyder
Timothy Hla
May H Han
机构
[1] Stanford University School of Medicine,Department of Neurology and Neurological Sciences
[2] Graduate Program in Immunology,Division of Medical Sciences
[3] Harvard Medical School,Department of Genetics
[4] Stanford University School of Medicine,Department of Pediatrics, Division of Allergy
[5] Immunology and Rheumatology,Department of Neurosurgery
[6] Stanford University School of Medicine,Department of Pathology and Laboratory Medicine
[7] Center for Vascular Biology,Department of Pathology
[8] Weill Cornell Medical College,Department of Cell Biology
[9] Cornell University,undefined
[10] Stanford University School of Medicine,undefined
[11] Center for Vascular Biology,undefined
[12] University of Connecticut Health Center,undefined
来源
Nature Immunology | 2013年 / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
S1P1 is a sphingosine phosphate receptor expressed on lymphocytes. Han and colleagues show that phosphorylated S1P1 accumulates in brain lesions of patients with multiple sclerosis. Similarly, mice bearing mutant S1P1 develop more severe experimental autoimmune encephalomyelitis.
引用
收藏
页码:1166 / 1172
页数:6
相关论文
共 50 条
  • [1] Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
    Garris, Christopher S.
    Wu, Linfeng
    Acharya, Swati
    Arac, Ahmet
    Blaho, Victoria A.
    Huang, Yingxiang
    Moon, Byoung San
    Axtell, Robert C.
    Ho, Peggy P.
    Steinberg, Gary K.
    Lewis, David B.
    Sobel, Raymond A.
    Han, David K.
    Steinman, Lawrence
    Snyder, Michael P.
    Hla, Timothy
    Han, May H.
    NATURE IMMUNOLOGY, 2013, 14 (11) : 1166 - U128
  • [2] Palmitoylation of the sphingosine 1-phosphate receptor S1P1 and sphingosine kinase
    Kihara, A.
    Ohno, Y.
    Igarashi, Y.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2006, 143 (1-2) : 99 - 99
  • [3] Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
    Cahalan, Stuart M.
    Gonzalez-Cabrera, Pedro J.
    Nhan Nguyen
    Guerrero, Miguel
    Cisar, Elizabeth A. George
    Leaf, Nora B.
    Brown, Steven J.
    Roberts, Edward
    Rosen, Hugh
    MOLECULAR PHARMACOLOGY, 2013, 83 (02) : 316 - 321
  • [4] Defective sphingosine-1-phosphate receptor 1 (S1PR1) internalization exacerbates autoimmune neuroinflammation by enhancing Stat3-mediated Th17 polarization
    Garris, C. S.
    Acharya, S.
    Axtell, R.
    Lewis, D.
    Sobel, R. A.
    Steinman, L.
    Hla, T.
    Han, M. H.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 510 - 510
  • [5] Multiple functions of the sphingosine 1-phosphate receptor S1P1 in endothelial cells
    Krump-Konvalinkova, V
    Rubic, T
    Vosseler, C
    Erl, W
    Yasuda, S
    Tigyi, G
    Kirkpatrick, JC
    Siess, W
    JOURNAL OF VASCULAR RESEARCH, 2004, 41 (01) : 110 - 110
  • [6] Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists
    Hennessy, Edward J.
    Grewal, Gurmit
    Byth, Kate
    Kamhi, Victor M.
    Li, Danyang
    Lyne, Paul
    Oza, Vibha
    Ronco, Lucienne
    Rooney, Michael T.
    Saeh, Jamal C.
    Su, Qibin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (10) : 2041 - 2045
  • [7] Induction of experimental autoimmune encephalomyelitis (EAE) in type 1 sphingosine 1-phosphate receptor (S1P1) transgenic mice
    Huang, MC
    Goetzl, EJ
    FASEB JOURNAL, 2006, 20 (05): : A1322 - A1323
  • [8] Inhibition of Ca2+ signalling by the sphingosine 1-phosphate receptor S1P1
    Heringdorf, DMZ
    Vincent, MEM
    Lipinski, M
    Danneberg, K
    Stropp, U
    Wang, D
    Tigyi, G
    Jakobs, KH
    CELLULAR SIGNALLING, 2003, 15 (07) : 677 - 687
  • [9] Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease
    Martinez-Gardeazabal, Jonatan
    Pereira-Castelo, Gorka
    Moreno-Rodriguez, Marta
    Llorente-Ovejero, Alberto
    Fernandez, Manuel
    Fernandez-Vega, Ivan
    Manuel, Ivan
    Rodriguez-Puertas, Rafael
    NEUROBIOLOGY OF DISEASE, 2024, 202
  • [10] Cenerimod Sphingosine 1-phosphate receptor 1 (S1P1) agonist Treatment of systemic lupus erythematosus
    Tanturovska, B. Stepanovska
    Huwiler, A.
    DRUGS OF THE FUTURE, 2020, 45 (11) : 785 - 797